Historical perspectives and guidelines for botulinum neurotoxin subtype nomenclature

Toxins

Volumn 9, Issue 1, 2017, Pages

  Peck, Michael W ^a   Smith, Theresa J ^b   Anniballi, Fabrizio ^c   Austin, John W ^d   Bano, Luca ^e   Bradshaw, Marite ^f   Cuervo, Paula ^g   Cheng, Luisa W ^h   Derman, Yagmur ⁱ   Dorner, Brigitte G ^j   Fisher, Audrey ^k   Hill, Karen K ^l   Kalb, Suzanne R ^m   Korkeala, Hannu ⁱ   Lindström, Miia ⁱ   Lista, Florigio ⁿ   Lúquez, Carolina ^o   Mazuet, Christelle ^p   Pirazzini, Marco ^q   Popoff, Michel R ^p   Rossetto, Ornella ^q   Rummel, Andreas ^r   Sesardic, Dorothea ^s   Singh, Bal Ram ^t   Stringer, Sandra C ^a   more..

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d HEALTH CANADA   (Canada)

^e ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE   (Italy)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

^g Universidad Nacional de Cuyo Facultad de Ciencias Medicas   (Argentina)

^h WESTERN REGIONAL RESEARCH CENTER   (United States)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

^j ROBERT KOCH INSTITUTE   (Germany)

^k JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY   (United States)

^l LOS ALAMOS NATIONAL LABORATORY   (United States)

^m NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

ⁿ Army Medical and Veterinary Research Center   (Italy)

^o NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^p INSTITUT PASTEUR   (France)

^q UNIVERSITY OF PADOVA   (Italy)

^r HANNOVER MEDICAL SCHOOL   (Germany)

^s NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^t Botulinum Research Center Institute of Advanced Sciences   (United States)

more..

Author keywords

Botulinum; Botulism; Clostridium botulinum; Guidelines; Neurotoxins; Nomenclature; Subtypes

Indexed keywords

BOTULINUM TOXIN; GLYCOSYLATED PROTEIN; SYNAPTOTAGMIN I; SYNAPTOTAGMIN II;

CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM BUTYRICUM; CLOSTRIDIUM SPOROGENES; GENE SEQUENCE; HUMAN; LETHAL DOSE; NOMENCLATURE; PUBLIC HEALTH SERVICE; REVIEW; SEQUENCE ANALYSIS; SEROTYPING; CLASSIFICATION; CONSENSUS; HISTORY;

BOTULINUM TOXINS; CONSENSUS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; TERMINOLOGY AS TOPIC;

EID: 85010441097     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins9010038     Document Type: Review

References (113)

1. Arnon, S.S.; Schechter, R.; Inglesby, T.V.; Henderson, D.A.; Bartlett, J.G.; Ascher, M.S.; Eitzen, E.; Fine, A.D.; Hauer, J.; Layton, M.; et al. Botulinum toxin as a biological weapon: Medical and public health management. JAMA 2001, 285, 1059-1070
2. Dolman, C.E.; Murikami, L. Clostridium botulinum type F with recent observations on other types. J. Infect. Dis. 1961, 109, 107-128
3. Smith, T.J.; Roxas-Duncan, V.I.; Smith, L.A. Botulinum neurotoxins as biothreat agents. J. Bioterr. Biodef. 2012, S7
4. Rummel, A. The long journey of botulinum neurotoxins into the synapse. Toxicon 2015, 107, 9-24
5. Rossetto, O.; Pirazzini, M.; Montecucco, C. botulinum neurotoxins: Genetic, structural and mechanistic insights. Nat. Rev. Microbiol. 2014, 12, 535-549
6. Fischer, A.; Montal, M. Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function. Toxicon 2013, 75, 101-107
7. Poulain, B.; Popoff, M.R.; Molgo, J. How do the botulinum toxins block neurotransmitter release: From botulism to the molecular mechanism of action. Botulinum J. 2008, 1, 14-87
8. Pantano, S.; Montecucco, C. The blockade of the neurotransmitter release apparatus by botulinum neurotoxins. Cell. Mol. Life Sci. 2014, 71, 793-811
9. Binz, T. Clostridial neurotoxin light chains: Devices for snare cleavage mediated blockade of neurotransmission. Curr. Top. Microbiol. Immunol. 2013, 364, 139-157
10. Yao, G.; Zhang, S.; Mahrhold, S.; Lam, K.H.; Stern, D.; Bagramyan, K.; Perry, K.; Kalkum, M.; Rummel, A.; Dong, M.; et al. N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A. Nat. Struct. Mol. Biol. 2016, 23, 656-662
11. Mahrhold, S.; Rummel, A.; Bigalke, H.; Davletov, B.; Binz, T. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett. 2006, 580, 2011-2014
12. Dong, M.; Yeh, F.; Tepp, W.H.; Dean, C.; Johnson, E.A.; Janz, R.; Chapman, E.R. SV2 is the protein receptor for botulinum neurotoxin A. Science 2006, 312, 592-596
13. Dong, M.; Richards, D.A.; Goodnough, M.C.; Tepp, W.H.; Johnson, E.A.; Chapman, E.R. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol. 2003, 162, 1293-1303
14. Dong, M.; Tepp, W.H.; Liu, H.; Johnson, E.A.; Chapman, E.R. Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons. J. Cell Biol. 2007, 179, 1511-1522
15. Strotmeier, J.; Gu, S.; Jutzi, S.; Mahrhold, S.; Zhou, J.; Pich, A.; Eichner, T.; Bigalke, H.; Rummel, A.; Jin, R.; et al. The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites. Mol. Microbiol. 2011, 81, 143-156
16. Peng, L.; Tepp, W.H.; Johnson, E.A.; Dong, M. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. PLoS Pathog. 2011, 7
17. Peng, L.; Berntsson, R.P.; Tepp, W.H.; Pitkin, R.M.; Johnson, E.A.; Stenmark, P.; Dong, M. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins. J. Cell Sci. 2012, 125, 3233-3242
18. Dong, M.; Liu, H.; Tepp, W.H.; Johnson, E.A.; Janz, R.; Chapman, E.R. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol. Biol. Cell 2008, 19, 5226-5237
19. Mahrhold, S.; Strotmeier, J.; Garcia-Rodriguez, C.; Lou, J.; Marks, J.D.; Rummel, A.; Binz, T. Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E. Biochem. J. 2013, 453, 37-47
20. Fu, Z.; Chen, C.; Barbieri, J.T.; Kim, J.J.; Baldwin, M.R. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry 2009, 48, 5631-5641
21. Rummel, A.; Hafner, K.; Mahrhold, S.; Darashchonak, N.; Holt, M.; Jahn, R.; Beermann, S.; Karnath, T.; Bigalke, H.; Binz, T. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor. J. Neurochem. 2009, 110, 1942-1954
22. Rummel, A.; Karnath, T.; Henke, T.; Bigalke, H.; Binz, T. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J. Biol. Chem. 2004, 279, 30865-30870
23. Kalb, S.R.; Baudys, J.; Webb, R.P.; Wright, P.; Smith, T.J.; Smith, L.A.; Fernandez, R.; Raphael, B.H.; Maslanka, S.E.; Pirkle, J.L.; et al. Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5. FEBS Lett. 2012, 586, 109-115
24. Leuchs, J. Beitraege zur kenntnis des toxins und antitoxins des Bacillus botulinus. Z. Hyg. Infekt. 1910, 76, 55-84
25. Burke, G.S. Notes on Bacillus botulinus. J. Bacteriol. 1919, 4, 555-570
26. Smith, L.D. The occurrence of Clostridium botulinum and Clostridium tetani in the soil of the United States. Health Lab. Sci. 1978, 15, 74-80
27. Meyer, K.; Dubovsky, B. The distribution of spores of B. botulinus in the United States. IV. J. Infect. Dis. 1922, 31, 559-594
28. Dover, N.; Barash, J.R.; Hill, K.K.; Xie, G.; Arnon, S.S. Molecular characterization of a novel botulinum neurotoxin type H gene. J. Infect. Dis. 2014, 209, 192-202
29. Barash, J.R.; Arnon, S.S. A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. J. Infect. Dis. 2014, 209, 183-191
30. Maslanka, S.E.; Luquez, C.; Dykes, J.K.; Tepp, W.H.; Pier, C.L.; Pellett, S.; Raphael, B.H.; Kalb, S.R.; Barr, J.R.; Rao, A.; et al. A novel botulinum neurotoxin, previously reported as serotype H, has a hybrid-like structure with regions of similarity to the structures of serotypes A and F and is neutralized with serotype A antitoxin. J. Infect. Dis. 2016, 213, 379-385
31. Pellett, S.; Tepp, W.H.; Bradshaw, M.; Kalb, S.R.; Dykes, J.K.; Lin, G.; Nawrocki, E.M.; Pier, C.L.; Barr, J.R.; Maslanka, S.E.; et al. Purification and characterization of botulinum neurotoxin FA from a genetically modified Clostridium botulinum strain. mSphere 2016, 1
32. Fan, Y.; Barash, J.R.; Lou, J.; Conrad, F.; Marks, J.D.; Arnon, S.S. Immunological characterization and neutralizing ability of monoclonal antibodies directed against botulinum neurotoxin type H. J. Infect. Dis. 2016, 213, 1606-1614
33. Kalb, S.R.; Baudys, J.; Raphael, B.H.; Dykes, J.K.; Luquez, C.; Maslanka, S.E.; Barr, J.R. Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A). Anal. Chem. 2015, 87, 3911-3917
34. Pfenninger, W. Toxico, immunologic and serologic relationship of B. botulinus, type C and B. parabotulinus. J. Infect. Dis. 1924, 35, 347-352
35. Moriishi, K.; Koura, M.; Abe, N.; Fujii, N.; Fujinaga, Y.; Inoue, K.; Oguma, K. Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms. Biochim. Biophys. Acta 1996, 1307, 123-126
36. Gimenez, D.F.; Ciccarelli, A.S. Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum. Medicina (B. Aires) 1972, 32, 596-606
37. Gimenez, D.F. Seological classification and typing of Clostridium botulinum. Dev. Biol. Stand. 1976, 32, 175-183
38. Torii, Y.; Shinmura, M.; Kohda, T.; Kozaki, S.; Takahashi, M.; Ginnaga, A. Differences in immunological responses of polyclonal botulinum A1 and A2 antitoxin against A1 and A2 toxin. Toxicon 2013, 73, 9-16
39. Tepp, W.H.; Lin, G.; Johnson, E.A. Purification and characterization of a novel subtype A3 botulinum neurotoxin. Appl. Environ. Microbiol. 2012, 78, 3108-3113
40. Gimenez, D.F.; Ciccarelli, A.S. Studies on strain 84 of Clostridium botulinum. Z. Bakteriol. Orig. 1970, 215, 212-220.
41. Gimenez, D.F.; Gimenez, J.A. Serological subtrypes of botulinal neurotoxins. In Botulinum and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects; DasGupta, B.R., Ed.; Plenum Press: New York, NY, USA, 1993; pp. 421-432.
42. Franciosa, G.; Maugliani, A.; Scalfaro, C.; Aureli, P. Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains. PLoS ONE 2009, 4
43. Peck, M.W.; Stringer, S.C.; Carter, A.T. Clostridium botulinum in the post-genomic era. Food Microbiol. 2011, 28, 183-191
44. Kozaki, S.; Kamata, Y.; Nishiki, T.; Kakinuma, H.; Maruyama, H.; Takahashi, H.; Karasawa, T.; Yamakawa, K.; Nakamura, S. Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in Japan. Infect. Immun. 1998, 66, 4811-4816
45. Smith, T.J.; Lou, J.; Geren, I.N.; Forsyth, C.M.; Tsai, R.; Laporte, S.L.; Tepp, W.H.; Bradshaw, M.; Johnson, E.A.; Smith, L.A.; et al. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect. Immun. 2005, 73, 5450-5457
46. Arndt, J.W.; Jacobson, M.J.; Abola, E.E.; Forsyth, C.M.; Tepp, W.H.; Marks, J.D.; Johnson, E.A.; Stevens, R.C. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4. J. Mol. Biol. 2006, 362, 733-742
47. Sebaihia, M.; Peck, M.W.; Minton, N.P.; Thomson, N.R.; Holden, M.T.; Mitchell, W.J.; Carter, A.T.; Bentley, S.D.; Mason, D.R.; Crossman, L.; et al. Genome sequence of a proteolytic (group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. Genome Res. 2007, 17, 1082-1092
48. Hill, K.K.; Xie, G.; Foley, B.T.; Smith, T.J. Genetic diversity within the botulinum neurotoxin-producing bacteria and their neurotoxins. Toxicon 2015, 107, 2-8
49. Williamson, C.H.; Sahl, J.W.; Smith, T.J.; Xie, G.; Foley, B.T.; Smith, L.A.; Fernandez, R.A.; Lindstrom, M.; Korkeala, H.; Keim, P.; et al. Comparative genomic analyses reveal broad diversity in botulinum-toxin-producing clostridia. BMC Genom. 2016, 17
50. Binz, T.; Kurazono, H.; Wille, M.; Frevert, J.; Wernars, K.; Niemann, H. The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins. J. Biol. Chem. 1990, 265, 9153-9158
51. Thompson, D.E.; Brehm, J.K.; Oultram, J.D.; Swinfield, T.J.; Shone, C.C.; Atkinson, T.; Melling, J.; Minton, N.P. The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene. Eur. J. Biochem. 1990, 189, 73-81
52. Whelan, S.M.; Elmore, M.J.; Bodsworth, N.J.; Brehm, J.K.; Atkinson, T.; Minton, N.P. Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence. Appl. Environ. Microbiol. 1992, 58, 2345-2354
53. Hauser, D.; Eklund, M.W.; Kurazono, H.; Binz, T.; Niemann, H.; Gill, D.M.; Boquet, P.; Popoff, M.R. Nucleotide sequence of Clostridium botulinum C1 neurotoxin. Nucleic Acids Res. 1990, 18, 4924
54. Binz, T.; Kurazono, H.; Popoff, M.R.; Eklund, M.W.; Sakaguchi, G.; Kozaki, S.; Krieglstein, K.; Henschen, A.; Gill, D.M.; Niemann, H. Nucleotide sequence of the gene encoding Clostridium botulinum neurotoxin type D. Nucleic Acids Res. 1990, 18, 5556
55. Whelan, S.M.; Elmore, M.J.; Bodsworth, N.J.; Atkinson, T.; Minton, N.P. The complete amino acid sequence of the Clostridium botulinum type E neurotoxin, derived by nucleotide-sequence analysis of the encoding gene. Eur. J. Biochem. 1992, 204, 657-667
56. East, A.K.; Richardson, P.T.; Allaway, D.; Collins, M.D.; Roberts, T.A.; Thompson, D.E. Sequence of the gene encoding type F neurotoxin of Clostridium botulinum. FEMS Microbiol. Lett. 1992, 75, 225-230
57. Campbell, K.; Collins, M.D.; East, A.K. Nucleotide sequence of the gene coding for Clostridium botulinum (Clostridium argentinense) type G neurotoxin: Genealogical comparison with other clostridial neurotoxins. Biochim. Biophys. Acta 1993, 1216, 487-491
58. Poulet, S.; Hauser, D.; Quanz, M.; Niemann, H.; Popoff, M.R. Sequences of the botulinal neurotoxin E derived from Clostridium botulinum type E (strain Beluga) and Clostridium butyricum (strains ATCC 43181 and ATCC 43755). Biochem. Biophys. Res. Commun. 1992, 183, 107-113
59. Willems, A.; East, A.K.; Lawson, P.A.; Collins, M.D. Sequence of the gene coding for the neurotoxin of Clostridium botulinum type A associated with infant botulism: Comparison with other clostridial neurotoxins. Res. Microbiol. 1993, 144, 547-556
60. Hutson, R.A.; Zhou, Y.; Collins, M.D.; Johnson, E.A.; Hatheway, C.L.; Sugiyama, H. Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences. J. Biol. Chem. 1996, 271, 10786-10792
61. Hutson, R.A.; Collins, M.D.; East, A.K.; Thompson, D.E. Nucleotide sequence of the gene coding for non-proteolytic Clostridium botulinum type B neurotoxin: Comparison with other clostridial neurotoxins. Curr. Microbiol. 1994, 28, 101-110
62. Santos-Buelga, J.A.; Collins, M.D.; East, A.K. Characterization of the genes encoding the botulinum neurotoxin complex in a strain of Clostridium botulinum producing type B and F neurotoxins. Curr. Microbiol. 1998, 37, 312-318
63. East, A.K.; Bhandari, M.; Hielm, S.; Collins, M.D. Analysis of the botulinum neurotoxin type F gene clusters in proteolytic and nonproteolytic Clostridium botulinum and Clostridium barati. Curr. Microbiol. 1998, 37, 262-268
64. Franciosa, G.; Ferreira, J.L.; Hatheway, C.L. Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: Evidence of unexpressed type B toxin genes in type A toxigenic organisms. J. Clin. Microbiol. 1994, 32, 1911-1917
65. Hill, K.K.; Smith, T.J. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. Curr. Top. Microbiol. Immunol. 2013, 364, 1-20
66. Shone, C.; Wilton-Smith, P.; Appleton, N.; Hambleton, P.; Modi, N.; Gatley, S.; Melling, J. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay. Appl. Environ. Microbiol. 1985, 50, 63-67
67. Notermans, S.; Kozaki, S.; Kamata, Y.; Sakaguchi, G. Use of monoclonal antibodies in enzyme linked immunosorbent assay (ELISA) for detection of botulinum type B toxins. Jpn. J. Med. Sci. Biol. 1984, 37, 137-140
68. Oguma, K.; Agui, T.; Syuto, B.; Kimura, K.; Iida, H.; Kubo, S. Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum. Infect. Immun. 1982, 38, 14-20
69. Kozaki, S.; Kamata, Y.; Nagai, T.; Ogasawara, J.; Sakaguchi, G. The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin. Infect. Immun. 1986, 52, 786-791
70. Gibson, A.M.; Modi, N.K.; Roberts, T.A.; Hambleton, P.; Melling, J. Evaluation of a monoclonal antibody-based immunoassay for detecting type B Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system. J. Appl. Bacteriol. 1988, 64, 285-291
71. Kozaki, S.; Nakaue, S.; Kamata, Y. Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan. Microbiol. Immunol. 1995, 39, 767-774
72. Hill, K.K.; Smith, T.J.; Helma, C.H.; Ticknor, L.O.; Foley, B.T.; Svensson, R.T.; Brown, J.L.; Johnson, E.A.; Smith, L.A.; Okinaka, R.T.; et al. Genetic diversity among botulinum neurotoxin-producing clostridial strains. J. Bacteriol. 2007, 189, 818-832
73. Umeda, K.; Seto, Y.; Kohda, T.; Mukamoto, M.; Kozaki, S. Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan. J. Clin. Microbiol. 2009, 47, 2720-2728
74. Carter, A.T.; Paul, C.J.; Mason, D.R.; Twine, S.M.; Alston, M.J.; Logan, S.M.; Austin, J.W.; Peck, M.W. Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genom. 2009, 10
75. Peck, M.W. Biology and genomic analysis of Clostridium botulinum. Adv. Microb. Physiol. 2009, 55, 183-265
76. Raphael, B.H.; Choudoir, M.J.; Luquez, C.; Fernandez, R.; Maslanka, S.E. Sequence diversity of genes encoding botulinum neurotoxin type F. Appl. Environ. Microbiol. 2010, 76, 4805-4812
77. Jacobson, M.J.; Lin, G.; Tepp, W.; Dupuy, J.; Stenmark, P.; Stevens, R.C.; Johnson, E.A. Purification, modeling, and analysis of botulinum neurotoxin subtype A5 (BoNT/A5) from Clostridium botulinum strain A661222. Appl. Environ. Microbiol. 2011, 77, 4217-4222
78. Raphael, B.H.; Lautenschlager, M.; Kalb, S.R.; de Jong, L.I.; Frace, M.; Luquez, C.; Barr, J.R.; Fernandez, R.A.; Maslanka, S.E. Analysis of a unique Clostridium botulinum strain from the southern hemisphere producing a novel type E botulinum neurotoxin subtype. BMC Microbiol. 2012, 12
79. Wangroongsarb, P.; Kohda, T.; Jittaprasartsin, C.; Suthivarakom, K.; Kamthalang, T.; Umeda, K.; Sawanpanyalert, P.; Kozaki, S.; Ikuta, K. Molecular characterization of Clostridium botulinum isolates from foodborne outbreaks in Thailand, 2010. PLoS ONE 2014, 9
80. Weedmark, K.A.; Lambert, D.L.; Mabon, P.; Hayden, K.L.; Urfano, C.J.; Leclair, D.; Van Domselaar, G.; Austin, J.W.; Corbett, C.R. Two novel toxin variants revealed by whole-genome sequencing of 175 Clostridium botulinum type E strains. Appl. Environ. Microbiol. 2014, 80, 6334-6345
81. Kull, S.; Schulz, K.M.; Weisemann, J.; Kirchner, S.; Schreiber, T.; Bollenbach, A.; Dabrowski, P.W.; Nitsche, A.; Kalb, S.R.; Dorner, M.B.; et al. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype. PLoS ONE 2015, 10
82. Mazuet, C.; Sautereau, J.; Legeay, C.; Bouchier, C.; Bouvet, P.; Popoff, M.R. An atypical outbreak of food-borne botulism due to Clostridium botulinum types B and E from ham. J. Clin. Microbiol. 2015, 53, 722-726
83. Giordani, F.; Fillo, S.; Anselmo, A.; Palozzi, A.M.; Fortunato, A.; Gentile, B.; Azarnia Tehran, D.; Ciammaruconi, A.; Spagnolo, F.; Pittiglio, V.; et al. Genomic characterization of Italian Clostridium botulinum group I strains. Infect. Genet. Evol. 2015, 36, 62-71
84. Pier, C.L.; Chen, C.; Tepp, W.H.; Lin, G.; Janda, K.D.; Barbieri, J.T.; Pellett, S.; Johnson, E.A. Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1. FEBS Lett. 2011, 585, 199-206
85. Whitemarsh, R.C.; Tepp, W.H.; Bradshaw, M.; Lin, G.; Pier, C.L.; Scherf, J.M.; Johnson, E.A.; Pellett, S. Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro. Infect. Immun. 2013, 81, 3894-3902
86. Bradshaw, M.; Tepp, W.H.; Whitemarsh, R.C.; Pellett, S.; Johnson, E.A. Holotoxin activity of botulinum neurotoxin subtype A4 originating from a nontoxigenic Clostridium botulinum expression system. Appl. Environ. Microbiol. 2014, 80, 7415-7422
87. Whitemarsh, R.C.; Tepp, W.H.; Johnson, E.A.; Pellett, S. Persistence of botulinum neurotoxin A subtypes 1-5 in primary rat spinal cord cells. PLoS ONE 2014, 9
88. Pellett, S.; Tepp, W.H.; Whitemarsh, R.C.; Bradshaw, M.; Johnson, E.A. In vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1-5. Toxicon 2015, 107, 37-42
89. Macdonald, T.E.; Helma, C.H.; Shou, Y.; Valdez, Y.E.; Ticknor, L.O.; Foley, B.T.; Davis, S.W.; Hannett, G.E.; Kelly-Cirino, C.D.; Barash, J.R.; et al. Analysis of Clostridium botulinum serotype E strains by using multilocus sequence typing, amplified fragment length polymorphism, variable-number tandem-repeat analysis, and botulinum neurotoxin gene sequencing. Appl. Environ. Microbiol. 2011, 77, 8625-8634
90. Chen, Y.; Korkeala, H.; Aarnikunnas, J.; Lindstrom, M. Sequencing the botulinum neurotoxin gene and related genes in Clostridium botulinum type E strains reveals orfX3 and a novel type E neurotoxin subtype. J. Bacteriol. 2007, 189, 8643-8650
91. Mansfield, M.J.; Adams, J.B.; Doxey, A.C. Botulinum neurotoxin homologs in non-clostridium species. FEBS Lett. 2015, 589, 342-348
92. Zornetta, I.; Azarnia Tehran, D.; Arrigoni, G.; Anniballi, F.; Bano, L.; Leka, O.; Zanotti, G.; Binz, T.; Montecucco, C. The first non clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain. Sci. Rep. 2016, 6
93. Hatheway, C.L. Bacteriology and pathology of neurotoxigenic clostridia. In Botulinum and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects; DasGupta, B.R., Ed.; Plenum Press: New York, NY, USA, 1993; pp. 491-503.
94. Carter, A.T.; Peck, M.W. Genomes, neurotoxins and biology of Clostridium botulinum Group I and Group II. Res. Microbiol. 2015, 166, 303-317
95. Smith, T.J.; Hill, K.K.; Xie, G.; Foley, B.T.; Williamson, C.H.; Foster, J.T.; Johnson, S.L.; Chertkov, O.; Teshima, H.; Gibbons, H.S.; et al. Genomic sequences of six botulinum neurotoxin-producing strains representing three clostridial species illustrate the mobility and diversity of botulinum neurotoxin genes. Infect. Genet. Evol. 2015, 30, 102-113
96. Skarin, H.; Hafstrom, T.; Westerberg, J.; Segerman, B. Clostridium botulinum Group III: A group with dual identity shaped by plasmids, phages and mobile elements. BMC Genom. 2011, 12
97. Keto-Timonen, R.; Heikinheimo, A.; Eerola, E.; Korkeala, H. Identification of Clostridium species and DNA fingerprinting of Clostridium perfringens by amplified fragment length polymorphism analysis. J. Clin. Microbiol. 2006, 44, 4057-4065
98. Suen, J.C.; Hatheway, C.L.; Steigerwalt, A.G.; Brenner, D.J. Genetic confirmation of identities of neurotoxigenic Clostridium baratii and Clostridium butyricum implicated as agents of infant botulism. J. Clin. Microbiol. 1988, 26, 2191-2192
99. Carter, A.T.; Stringer, S.C.; Webb, M.D.; Peck, M.W. The type F6 neurotoxin gene cluster locus of Group II Clostridium botulinum has evolved by successive disruption of two different ancestral precursors. Genome Biol. Evol. 2013, 5, 1032-1037
100. Lindstrom, M.K.; Jankola, H.M.; Hielm, S.; Hyytia, E.K.; Korkeala, H.J. Identification of Clostridium botulinum with API 20A, Rapid ID 32A and Rapid ANA II. FEMS Immunol. Med. Microbiol. 1999, 24, 267-274
101. Marshall, K.M.; Bradshaw, M.; Pellett, S.; Johnson, E.A. Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes. Biochem. Biophys. Res. Commun. 2007, 361, 49-54
102. Smith, T.J.; Hill, K.K.; Foley, B.T.; Detter, J.C.; Munk, A.C.; Bruce, D.C.; Doggett, N.A.; Smith, L.A.; Marks, J.D.; Xie, G.; et al. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3,/Ba4 and/B1 clusters are located within plasmids. PLoS ONE 2007, 2
103. Stringer, S.C.; Carter, A.T.; Webb, M.D.; Wachnicka, E.; Crossman, L.C.; Sebaihia, M.; Peck, M.W. Genomic and physiological variability within group II (non-proteolytic) Clostridium botulinum. BMC Genom. 2013, 14, 333
104. Carter, A.T.; Austin, J.W.; Weedmark, K.A.; Peck, M.W. Evolution of chromosomal Clostridium botulinum type E neurotoxin gene clusters: Evidence provided by their rare plasmid-borne counterparts. Genome Biol. Evol. 2016, 8, 540-555
105. Takeda, M.; Tsukamoto, K.; Kohda, T.; Matsui, M.; Mukamoto, M.; Kozaki, S. Characterization of the neurotoxins produced by isolates associated with avian botulism. Avian Dis. 2005, 49, 376-381
106. Sonnabend, O.; Sonnabend, W.; Heinzle, R.; Sigrist, T.; Dirnhofer, R.; Krech, U. Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: Report of five sudden unexpected deaths. J. Infect. Dis. 1981, 143, 22-27
107. Weigand, M.R.; Pena-Gonzalez, A.; Shirey, T.B.; Broeker, R.G.; Ishaq, M.K.; Konstantinidis, K.T.; Raphael, B.H. Implications of genome-based discrimination between Clostridium botulinum Group I and Clostridium sporogenes strains for bacterial taxonomy. Appl. Environ. Microbiol. 2015, 81, 5420-5429
108. Fillo, S.; Giordani, F.; Anselmo, A.; Fortunato, A.; Palozzi, A.M.; De Santis, R.; Ciammaruconi, A.; Spagnolo, F.; Anniballi, F.; Fiore, A.; et al. Draft genome sequence of Clostridium botulinum B2 450 strain from wound botulism in a drug user in italy. Genome Announc. 2015, 3
109. Van Ermengem, E. A new anaerobic bacillus and its relation to botulism (originally published as “Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus” in Zeitschrift für Hygiene und Infektionskrankheiten 26:1-56, 1897). Rev. Infect. Dis. 1897, 1, 701-719
110. Landmann, G. Ueber die Ursache der Darmstadter Bohnenvergiftung. Hyg. Rundsch. 1904, 14, 449-452
111. Das Gupta, B.R.; Sugiyama, H. Role of a protease in natural activation of Clostridium botulinum neurotoxin. Infect. Immun. 1972, 6, 587-590
112. DasGupta, B.R.; Sugiyama, H. A common subunit structure in Clostridium botulinum type A, B and E toxins. Biochem. Biophys. Res. Commun. 1972, 48, 108-112
113. Smith, T.J.; Hill, K.K.; Raphael, B.H. Historical and current perspectives on Clostridium botulinum diversity. Res. Microbiol. 2015, 166, 290-302